ftInvstr

GLAND · Healthcare ₹3285.0 +4.86% Mkt Cap ₹54252 Cr overvalued

GLAND

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹3285.0

+4.86% today · 30d +7.42%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for GLAND. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹1800 Cr

+19.57% YoY

NET PROFIT

₹317 Cr

+47.09% YoY

OPM

29.58%

+2.37pp YoY

EPS

₹19.23

PE 43.55

Intrinsic value · DCF ₹986.33 · Margin of safety -70.0% (overvalued) · FCF yield 1.0%

◇ Sector Position

PEERPEROCE %

GLAND43.5515.0

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 100

Valuation FAIR 40

Growth STRONG 82

Profitability HIGH 85

Technicals STRONG 70

Risk LOW 90

Key Stats

TTM PE

43.55

P/B

5.19

52W HIGH

₹3374.0

OFF HIGH

-2.64%

DIV YIELD

0.63%

MKT CAP

₹54252 Cr

◉ Active Signals

MACDBullish20.4717

RSI(14)Bullish68.54

Near 52W HighBullish-2.64

Street Consensus

14 analysts

₹3202.93

mean target

Low ₹1940.0Now ₹3285.0High ₹3920.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold GLAND and at what entry.